Akshay Jadhav

Non Invasive Prenatal Testing Market| Market Trends by Instruments, Consumables, Method, Applicationand End User

2019-03-14T21:28:39.228Z

The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.

The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021.

The instruments segment is divided into ultrasound device, NGS systems, PCR instruments, microarrays, and other instruments. In 2016, the consumables segment accounted for the largest share of the market. The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT.

Based on application, the market is divided into Trisomy, microdeletion syndrome, and other applications. Trisomy forms the largest and fastest-growing application segment of the global market. This is mainly attributed to the rising incidence of chromosomal abnormalities with increasing maternal age.

The global market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The market in Asia is expected to grow at the highest CAGR during the forecast period. Factors such as increasing awareness programs, high incidence of genetic disorders, increasing healthcare infrastructure, and rising disposable income are some of the factors contributing to the growth of the market in Asia.

Key Players:

Key market players are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).

Get More Details @ https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

Gas Chromatography Market |Market Analysis by Instrument, Accessories and Consumables, End User with Key Players

2019-03-14T20:49:00.326Z

In this report, the gas chromatography market is segmented on the basis of instruments, accessories and consumables, end users, and regions. The instruments market is segmented into systems, detectors, auto-samplers, and fraction collectors. The systems segment is projected to register the highest CAGR during the forecast period. The growth of this segment can primarily be attributed to factors such as increased capability to analyze complex compounds and technological advancements.

The global gas chromatography market is expected to reach USD 3.67 Billion by 2022 from USD 2.64 Billion in 2016, at a CAGR of 6.2%.

On the basis of accessories and consumables, the market is segmented into columns, column accessories, auto-sampler accessories, flow management consumables & accessories, fittings & tubing, pressure regulators, gas generators, and other accessories. The columns segment is expected to be the fastest-growing of the global gas chromatography market during the forecast period. The growth of this segment can primarily be attributed to factors such as discovery of new oil fields and the availability of improved gas chromatography columns for the petroleum industry.

On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific, and the RoW. Of these, North America accounted for the largest market share in 2016. Factors such as increase in the U.S. shale gas production, growing funding for environmental testing and clean-up in Canada, increasing funding for R&D activities in healthcare & environmental industries, and growing food testing industries are driving the growth of the North American gas chromatography market.

Key Players:

Key players in this market include Agilent Technologies, Inc. (U.S), Thermo Fisher Scientific, Inc. (U.S), Shimadzu Corporation (Japan), PerkinElmer, Inc. (U.S), Danaher Corporation (U.S), Scion instruments (Techcomp USA Inc.), Leco corporation (U.S), Merck KgaA (Germany), Falcon Analytical Systems &Technology, LLC (U.S), Restek Corporation (U.S), Dani Instruments S.P.A. (Italy) and Chromatotec (France). These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.

Get More Analysis @ https://www.marketsandmarkets.com/Market-Reports/gas-chromatography-market-101656773.html

Non-invasive Prenatal Testing Market :Lucrative Business Growth Opportunities

2019-03-13T20:30:55.341Z

The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period.

The non-invasive prenatal testing market is witnessing significant growth across the globe owing to factors such as high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, launch of new and advanced products, improving reimbursement scenario for NIPT, and programs focusing on increasing the awareness of NIPT. The increasing use of NIPT in detection of Trisomy (Down syndrome, Edwards’s syndrome, and Patau syndrome), Microdeletion syndrome, and other applications (Monogenic disorders, Klinefelter syndrome, gender detection, and rhesus (Rh) blood type) also play a vital role in the development of this market. Key players in the market focus on partnerships, collaborations, and agreements; product launches, expansions; and acquisitions to strengthen their positions in the global market.

The NIPT market is segmented based on product, method, application, end user, and region. On the basis of product, the market is segmented into consumables and instruments. The consumables segment offer lucrative growth opportunities and represent a new revenue pocket for the market owing to the repeated requirements of consumables in NIPT. The consumables segment is further divided into assay kits & reagents and disposables. The instruments segment is classified into ultrasound devices, NGS systems, PCR instruments, microarrays, and other instruments.

https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

Currently, North America dominates the market, followed by Europe. However, the market in Asia is expected to witness the highest growth due to the increasing healthcare infrastructure. In addition, increasing awareness programs, rising disposable income, and increasing interest of players to expand in these emerging economies will propel the growth of the market.

Global Glycomics Market Players Pursue the Strategies of Product Launches, Agreements, Expansions, Acquisitions, and Collaborations

2019-03-12T20:34:09.385Z

The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S.).

The glycomics market is dominated by a few major players, with the top five players accounting for a majority of the market share. The top four players for glycomics enzymes, kits, and reagents have a combined market share of about 75.2% and for glycomics instruments have a combined market share of about 76.0%.

The global glycomics market is highly evolved, with multiple different product segments. An analysis of market developments between 2011 and 2014 revealed that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by most players in this market, except New England Biolabs (U.S.) and Takara Bio, Inc. (Japan).

The other important growth strategy adopted by players in this market was expansion. This strategy was implemented to gain immediate technological competency and widen geographic presence. This strategy was adopted by all the players in this market, except Prozyme, Inc. (U.S.), and Waters Corporation (U.S.). Unlike their peers, these companies did not enter into any expansions between 2011 and 2014.

Know more Details @ https://www.marketsandmarkets.com/Market-Reports/glycobiology-market-132685525.html

GE Healthcare (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Becton, Dickinson and Company (U.S.) Dominate the Global High-content screening Market

2019-03-12T19:49:30.782Z

Thermo Fisher Scientific Inc. is one of the top players in the market. The company operates in more than 180 countries across North America, Europe, Asia, and Latin America. It offers HCS instruments and software among other products. The company focuses on product launches as its key business strategy. In May 2016, the company launched the Invitrogen Evos FL Auto 2 Imaging System to provide rapid capture and analysis of higher-quality images in live-cell imaging experiments. In addition, in January 2016, Thermo Fisher Scientific launched the Cell Insight CX7 high-content analysis platform. This strengthened the company’s hold in the HCS market.

The "High Content Screening Market is expected to reach USD 909.0 Million by 2022 from USD 557.1 Million in 2017, at a CAGR of 10.3%.

The factors expected to drive the growth of the market are rising need for cost containment in pharmaceutical R&D, growth in funding for cellular research, and technological advancements in HCS solutions during the forecast period. The increasing number of contract research organizations providing HCS outsourcing services and application of HCS in personalized medicine offer significant growth opportunities in the HCS market. The rising adoption of label-free technologies and growing focus on stem cell analysis are the key trends in the HCS market.

Key Players:-

The prominent players in the global high-content screening market are GE Healthcare (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group (Switzerland), BioTek Instruments Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).

Get market Details @ https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

High Content Screening Market worth $909.0 Million by 2022

2019-03-11T19:57:19.922Z

The factors expected to drive the growth of the market are growth in funding for cellular research, cost containment in pharma R&D, and technological advancements in HCS solutions. The rapid growth in developing countries across APAC is also expected to provide an opportunity for revenue generation in the market. However, the high cost of HCS instruments and the dearth of knowledgeable and skilled personnel for the operation of the instruments are expected to restrain the market growth.

The global high-content screening market is projected to reach USD 909.0 million by 2022 at a CAGR of 10.3% during the forecast period.

The market is segmented based on product, application, end user, and region. Based on product, the market is segmented into instruments, consumables, software, services, and accessories.

Based on application, the market is segmented into target identification and validation, primary and secondary screening, toxicity studies, compound profiling, and other applications such as angiogenesis, apoptosis, cell cycle and mitotic index, cell proliferation, endocytosis, protein synthesis, and stem cell differentiation. In 2016, the primary & secondary screening segment dominated the market. The dominant share of this segment is attributed to its wide usage in qualitative assays to exclude the compounds with unintended modes of action, evaluation of bioavailability and lead specificity.

North America is the largest market for high-content screening, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. High R&D expenditure, the presence of major lifesciences market players, and government support are some of the factors attributed to the large share of North America in the HCS market.

Key Players:

The major players in the market are GE Healthcare (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Becton, Dickinson and Company (U.S.). Some of the other leading players in this market include BioTek Instruments Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Tecan Group Ltd. (Switzerland), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).

View more details @ https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

Pharmaceutical Robots Market worth $119.5 Million by 2021

2019-03-11T19:45:01.337Z

This report segments the market based on type, application, and region. On the basis of type, the market is segmented into traditional robots and collaborative robots. The traditional robots segment is expected to command the largest share of the global market. However, the collaborative pharmaceutical robots segment is expected to register the highest CAGR of 36.6% during the forecast period. The ability to operate collaboratively with humans as well as their ability to be re-deployed easily is contributing to their growth during the forecast period.

The pharmaceutical robots market is projected to reach USD 119.5 million by 2021 from USD 64.4 million in 2016, at a CAGR of 13.2%.

On the basis of application, the global pharmaceutical robots market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications. In 2016, the picking and packaging segment accounted for the largest share of the global pharmaceutical robots market. Factors such as demand for personalized packaging configurations and advantages of robots in pharmaceutical manufacturing such as high speed, accuracy, ability to track and trace, error-free operation, fewer accidents, and better utilization of the floor space are contributing to the large share of the picking and packaging segment.

Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan) are some of the key players in the pharmaceutical robots market.

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-robot-market-210985096.html

Pharmaceutical Robots Market worth $119.5 Million by 2021

2019-03-11T19:20:14.924Z

The pharmaceutical robots market is projected to reach USD 119.5 million by 2021 from USD 64.4 million in 2016, at a CAGR of 13.2%.

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-robot-market-210985096.html

Pharmacy Automation Market worth $5.38 Billion by 2022

2019-03-11T18:21:05.384Z

According to the new market research report “Pharmacy Automation System Market by Product (Medication Dispensing System (Robot, Carousel), Packaging & Labeling System (Unit Dose, Multi Dose), Tabletop Counter, Storage System), End User (Inpatient, Outpatient, Retail Pharmacy) - Global Forecast to 2022", published by MarketsandMarkets™, The global pharmacy automation market is projected to reach USD 5.38 billion by 2022, at a CAGR of 8.2% from 2017 to 2022. The market growth can be attributed to a number of factors such as the growing need to minimize medication errors, rapid decentralization of pharmacies, changing population demographics, and rising labor costs.

Pharmacy automation systems refer to a variety of systems and software designed to increase the productivity of pharmacies and precision of the medication compounding process by reducing human intervention. Automated systems mechanize various procedures in pharmacies, including the storage, packaging, dispensing, pickup, delivery, and distribution of drugs.

The pharmacy automation market has been segmented on the basis of product, into automated medication dispensing systems, automated packaging and labelling systems, automated table top counters, automated medication compounding systems, automated storage and retrieval systems, and other pharmacy automation systems. The market for automated packaging and labelling systems is expected to grow at the highest CAGR between 2017 and 2022. On the other hand, among all the products, automated medication dispensing systems are most widely used. The high adoption of these instruments is contributing to the rapid growth of the market.

The leading position of McKesson can mainly be attributed to its well-established position in the pharmaceutical distribution business in the U.S. and Canada as well as its strong portfolio of pharmacy automation systems. In the last few years, the company has launched several products such as EnterpriseRx (a next-generation pharmacy software system), Your Pharmacy Online (a mobile application), ExpressRx Track (a pharmacy automation solution), ScanAbility (Barcode Medication Administration Analytics Tool), and McKesson Ambulatory Pharmacy Solutions, to name a few. These products have helped to reinforce the company’s product portfolio, thereby giving it a competitive advantage over other players in the market.

In 2016, North America accounted for the largest share of the global pharmacy automation market, largely attributed to the increasing number of drug prescriptions at pharmacies resulting from growth in the aging population.

The major players in the pharmacy automation market are Becton, Dickinson, and Company (U.S.), Omnicell, Inc. (U.S.), Cerner Corporation (U.S.), Capsa Healthcare (U.S.), Parata Systems LLC (U.S), Baxter International, Inc. (U.S.), ScriptPro LLC (U.S.), KUKA AG (Germany), TCGRx Pharmacy Workflow Solutions (U.S.), RxSafe, LLC (U.S.), ARxIUM Inc. (U.S.) and Talyst systems LLC. (U.S.).

Get More Details @ https://www.marketsandmarkets.com/Market-Reports/pharmacy-automation-systems-market-71522890.html

Gas Chromatography Market worth $3.67 Billion by 2022

2019-03-11T17:41:48.164Z

New market research report "Gas Chromatography Market by Instrument (Systems, Detectors), Accessories and Consumables (Columns, Column accessories, Pressure regulators, Gas generators),End user (Oil & Gas industry, Environmental agencies, Pharma & Biotech) - Global Forecast to 2022", published by MarketsandMarkets™, The global gas chromatography market is expected to reach USD 3.67 Billion by 2022 from USD 2.64 Billion in 2016, at a CAGR of 6.2%.

The gas chromatography market is segmented on the basis of instruments, accessories and consumables, end users, and regions. The instruments market is segmented into systems, detectors, auto-samplers, and fraction collectors. The systems segment is projected to register the highest CAGR during the forecast period. The growth of this segment can primarily be attributed to factors such as increased capability to analyze complex compounds and technological advancements.

Key players -

In this market include Agilent Technologies, Inc. (U.S), Thermo Fisher Scientific, Inc. (U.S), Shimadzu Corporation (Japan), PerkinElmer, Inc. (U.S), Danaher Corporation (U.S), Scion instruments (Techcomp USA Inc.), Leco corporation (U.S), Merck KgaA (Germany), Falcon Analytical Systems &Technology, LLC (U.S), Restek Corporation (U.S), Dani Instruments S.P.A. (Italy) and Chromatotec (France). These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.

Get More Details @ https://www.marketsandmarkets.com/Market-Reports/gas-chromatography-market-101656773.html